Joseph Burnett sold $1.1M of CLPT
CEO and President at ClearPoint Neuro, Inc.. 61,843 shares at an average of $17.79, traded Jun 17, 2026, filed Jun 22, 2026.
Score components
- +25RoleCEO
- +25Trade size$1.1M at market
- +10Share of holdings soldSold 35% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-277503, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | MOption exercise Common Stock10b5-1 | +60,000 | $2.50 | $150k | 176,842 | Jun 22, 2026 |
| Jun 17, 2026 | SOpen-market sale Common Stock10b5-1 | -60,000 | $17.79 | $1.1M | 116,842 | Jun 22, 2026 |
| Jun 17, 2026 | SOpen-market sale Common Stockindirect: See Footnote10b5-1 | -1,843 | $17.94 | $33k | 191,388 | Jun 22, 2026 |
| Jun 17, 2026 | MOption exercise Stock Options (right to buy)derivative10b5-1 | -60,000 | $0.00 | $0 | 270,000 | Jun 22, 2026 |
Related signals
Other insiders at ClearPoint Neuro, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 11Weak | ClearPoint Neuro, Inc. | Joseph Burnett CEO and President | $388k 20,000 shares | -15% | |
| 38Weak | ClearPoint Neuro, Inc. | Timothy T. Richards director | $66k 5,415 shares | -6% | |
| 52Moderate | ClearPoint Neuro, Inc. | Matthew B. Klein director | $185k 16,000 shares | -25% | |
| 2Weak | ClearPoint Neuro, Inc. | Lynnette C Fallon director | $57k 5,091 shares | -10% | |
| 19Weak | ClearPoint Neuro, Inc. | Joseph Burnett CEO and President | $303k 19,951 shares | -9% | |
| 11Weak | ClearPoint Neuro, Inc. | Joseph Burnett CEO and President | $46k 2,943 shares | -1% | |
| 24Weak | ClearPoint Neuro, Inc. | Joseph Burnett CEO and President | $322k 20,000 shares | -63% | |
| 31Weak | ClearPoint Neuro, Inc. | Joseph Burnett CEO and President | $714k 26,463 shares | -11% | |
| 46Moderate | ClearPoint Neuro, Inc. | Timothy T. Richards director | $133k 10,000 shares | -11% | |
| 54Moderate | ClearPoint Neuro, Inc. | Joseph Burnett CEO and President | $282k 21,247 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.